The National Center for Complementary and Integrative Health (NCCIH) is offering this U24 grant for the competing renewal of Data Coordinating Centers (DCCs) supporting multisite clinical trials. This grant aims to provide additional time to complete trials or for justified extended follow-up to assess longer-term outcomes. DCC applications must propose a comprehensive plan for project coordination, administration, data management, and biostatistical support. A corresponding Clinical Coordinating Center application can be submitted simultaneously if needed, or a single DCC application if data collection is centralized. Applicants should contact NCCIH before submitting.
Opportunity ID: 331257
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-21-116 |
| Funding Opportunity Title: | Limited Competition for the Continuation of Multisite Clinical Trial Data Coordinating Center (Collaborative U24 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.213 — Research and Training in Complementary and Integrative Health |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Feb 01, 2021 |
| Last Updated Date: | Feb 01, 2021 |
| Original Closing Date for Applications: | Sep 27, 2023 |
| Current Closing Date for Applications: | Sep 27, 2023 |
| Archive Date: | Nov 02, 2023 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $500,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Native American tribal governments (Federally recognized) State governments Others (see text field entitled “Additional Information on Eligibility” for clarification) For profit organizations other than small businesses County governments Public housing authorities/Indian housing authorities Private institutions of higher education Special district governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Public and State controlled institutions of higher education Independent school districts Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA), utilizing the U24 grant funding mechanism, encourages applications for competing renewal of Data Coordinating Center (DCC) for ongoing clinical trials supported by NCCIH. Extension of an ongoing clinical trial will be supported when there is need for additional time to complete the trial or when an extended period of follow up is well justified to assess longer term outcomes. The DCC competing renewal application must propose a comprehensive plan for completion of the clinical trial data collection that provides overall project coordination and administrative; data management; and biostatistical support for the ongoing clinical trial. Both a DCC application and a corresponding Clinical Coordinating Center application can be submitted simultaneously for consideration by NCCIH if both are needed to complete the ongoing. If clinical trial data collection and follow up can be completed centrally by the DCC and no study visits at clinical sites are needed, a single application for competing renewal for the DCC can be submitted. Applicants are strongly encouraged to contact the appropriate Scientific/Research contact for the ongoing clinical trial for which they are planning a competing renewal application prior to submitting to this FOA. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-21-116.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 331257 Full Announcement-PAR-21-116 -> PAR-21-116-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-F | Use for due dates on or before January 24, 2022 | PKG00265265 | Feb 15, 2021 | Jan 24, 2022 | View | |
| FORMS-G | Use for due dates on or before January 24, 2023 | PKG00269583 | Oct 27, 2021 | Jan 24, 2023 | View | |
| FORMS-H | Use for due dates on or after January 25, 2023 | PKG00277596 | Oct 31, 2022 | Sep 27, 2023 | View |
Package 1
Mandatory forms
331257 RR_SF424_2_0-2.0.pdf
331257 PHS398_CoverPageSupplement_5_0-5.0.pdf
331257 RR_OtherProjectInfo_1_4-1.4.pdf
331257 PerformanceSite_2_0-2.0.pdf
331257 RR_KeyPersonExpanded_2_0-2.0.pdf
331257 RR_Budget_1_4-1.4.pdf
331257 PHS398_ResearchPlan_4_0-4.0.pdf
331257 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
331257 RR_SubawardBudget30_1_4-1.4.pdf
331257 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
331257 RR_SF424_5_0-5.0.pdf
331257 PHS398_CoverPageSupplement_5_0-5.0.pdf
331257 RR_OtherProjectInfo_1_4-1.4.pdf
331257 PerformanceSite_4_0-4.0.pdf
331257 RR_KeyPersonExpanded_4_0-4.0.pdf
331257 RR_Budget_3_0-3.0.pdf
331257 PHS398_ResearchPlan_4_0-4.0.pdf
331257 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
331257 RR_SubawardBudget30_3_0-3.0.pdf
331257 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 3
Mandatory forms
331257 RR_SF424_5_0-5.0.pdf
331257 PHS398_CoverPageSupplement_5_0-5.0.pdf
331257 RR_OtherProjectInfo_1_4-1.4.pdf
331257 PerformanceSite_4_0-4.0.pdf
331257 RR_KeyPersonExpanded_4_0-4.0.pdf
331257 RR_Budget_3_0-3.0.pdf
331257 PHS398_ResearchPlan_5_0-5.0.pdf
331257 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
331257 RR_SubawardBudget30_3_0-3.0.pdf
331257 PHS_AssignmentRequestForm_3_0-3.0.pdf